California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

Press releases published on April 9, 2026

Apr. 9, 2026

Smith+Nephew’s REGENETEN◊ Bioinductive Implant shows post-operative recovery times halved, and high healing rates for partial-thickness rotator cuff tears1,*

Indeterminate GlobeNewswire

Apr. 9, 2026

AMN Healthcare to Hold First Quarter 2026 Earnings Conference Call on Thursday, May 7, 2026

Indeterminate GlobeNewswire

Apr. 9, 2026

Kura Oncology to Present Darlifarnib Plus Cabozantinib Data in Patients with Clear Cell Renal Cell Carcinoma Previously Treated with Cabozantinib at IKCS Europe 2026

Indeterminate GlobeNewswire

Apr. 9, 2026

Plus Therapeutics Appoints Eric J. Daniels, M.D., MBA, as Chief Development Officer to Advance Clinical Pipeline

Indeterminate GlobeNewswire

Apr. 9, 2026

InflaRx Reports New Mechanistic Data for Izicopan Supporting its Potential as a Best-in-Class C5aR Inhibitor

Indeterminate GlobeNewswire

Apr. 9, 2026

Weight Watchers Announces Board Committee Appointments

Indeterminate GlobeNewswire

Apr. 9, 2026

Invivyd Announces REVOLUTION Program Progress and Advancement of Novel, Potential First- and Best-in-Class Measles Monoclonal Antibody Candidate VMS063 for Treatment and Prevention of Measles

Indeterminate GlobeNewswire

Apr. 9, 2026

Indivior to Report First Quarter 2026 Financial Results and Host Webcast on April 30th  

Indeterminate GlobeNewswire

Apr. 9, 2026

Oxford BioTherapeutics Enters Strategic Collaboration with Bristol Myers Squibb to Discover and Develop Next-Generation T-cell Engagers for Solid Tumours

Indeterminate GlobeNewswire

Apr. 9, 2026

Soleo Health Opens New Ambulatory Infusion Center in Austin, Texas

Indeterminate GlobeNewswire

Apr. 9, 2026

Rani Therapeutics Appoints Dr. Sara Kenkare-Mitra as Strategic Advisor to Advance Platform and Clinical Strategy

Indeterminate GlobeNewswire

Apr. 9, 2026

Satellos to Present at the Bloom Burton & Co. Healthcare Investor Conference

Indeterminate GlobeNewswire

Apr. 9, 2026

Click Therapeutics and Boehringer Ingelheim Announce Series D Investment and Funding to Advance Commercialization of CT-155

Indeterminate GlobeNewswire

Apr. 9, 2026

Foghorn Therapeutics to Present New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting

Indeterminate GlobeNewswire

Apr. 9, 2026

Netramark-Authored, Peer-Reviewed Article Suggests Psychedelics Might Not Only Affect Brain Chemistry, They May Also Involve Quantum-Level Processes Inside the Brain

Indeterminate GlobeNewswire

Apr. 9, 2026

Kymera Therapeutics Announces Gilead Sciences’ Option Exercise to License KT-200, Oral CDK2 Molecular Glue Degrader Development Candidate

Indeterminate GlobeNewswire

Apr. 9, 2026

Seres Therapeutics to Present at CARB-X Investor Day

Indeterminate GlobeNewswire

Apr. 9, 2026

Nkarta to Participate in Needham Virtual Healthcare Conference

Indeterminate GlobeNewswire

Apr. 9, 2026

Medicenna Therapeutics Appoints Dr. Nageatte Ibrahim as Chief Medical Officer

Indeterminate GlobeNewswire

Apr. 9, 2026

C4 Therapeutics Expands Long-Term Partnership with Roche Through New Collaboration Agreement Focused on Discovering and Developing Degrader-Antibody Conjugates (DACs)

Indeterminate GlobeNewswire